Cell
Hybrid Top Tier Verified Publisher
About Cell
Cell is a prominent academic journal specializing in Cell Biology, Genetics and Life Sciences. Published by Elsevier in US, the journal serves as an essential platform for researchers to share high-quality scholarly work. It is a subscription-based publication identified by ISSN 0092-8674. With a current Impact Factor of 64.500, Cell maintains rigorous standards of Peer Review and academic excellence. The journal aims to advance the boundaries of knowledge within its research areas and provides valuable insights for the global scientific community.
Editorial Perspective & Metric Analysis
Based on current metadata, Cell maintains a high-tier position in the US academic market. With an impact factor of 64.50, it remains a highly cited venue for researchers in its specific sub-fields.
Submission Tips for Cell
- Average time to first decision: 94 days.
How Cell Compares
Compared against 6 journals in the same research areas.
| ISSN (Print) | 0092-8674 |
|---|---|
| ISSN (Online) | 1097-4172 |
| Publisher | Elsevier |
| Country | United States |
| Established | 1974 |
| APC / Cost | $9900 USD |
About Cell
Cell is a prominent academic journal specializing in Cell Biology, Genetics and Life Sciences. Published by Elsevier in US, the journal serves as an essential platform for researchers to share high-quality scholarly work. It is a subscription-based publication identified by ISSN 0092-8674. With a current impact factor of 64.500, Cell maintains rigorous standards of peer review and academic excellence. The journal aims to advance the boundaries of knowledge within its research areas and provides valuable insights for the global scientific community.
Research Areas
Frequently Asked Questions about Cell
Live Indexing Status
Updated March 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Impact Factor
Historical Trend
The impact factor has grown by 78% over the last 5 years (from 36.200 to 64.500), indicating rising influence.
Impact Factors by Year
| Year | Value | Source |
|---|---|---|
| 2024 | 64.500 | Journal Citation Reports (Clarivate) |
| 2023 | 61.275 | Journal Citation Reports (Clarivate) |
| 2022 | 66.800 | Journal Citation Reports (Clarivate) |
| 2021 | 41.500 | Journal Citation Reports (Clarivate) |
| 2020 | 38.600 | Journal Citation Reports (Clarivate) |
Journal Metrics
Research Highlights
Recently published high-impact papers in this journal:
-
MYBPC3 (c.194 C > T) mutation-mediated RyR2 dysfunction contributes to pathogenic phenotypes of DCM revealed by HiPSC modeling
Manting Xie, Bingbing Xie, Liang Huang • 2026
-
Is asciminib an effective tyrosine kinase inhibitor for chronic myeloid leukemia patients with tyrosine kinase inhibitor resistance?
Musab M. A. Omar, Majed A Alanazi, Denise E. Jackson • 2026
-
The Double-Edged Sword Effect of the Fibrinolytic System in Alzheimer’s Disease
Mingqing Tang, Meimei Liang, Xianying Zhang • 2026
-
Hallmarks of the pre-disease state: prevention and control of the pre-disease state, a tipping point between health and disease
Pei Chen, Tong Wang, Rui Liu • 2026
-
Sugen kinase 495 promotes the proliferation, migration and invasion of lung squamous cell carcinoma cells by targeting Foxo1 transcription factor
Yuanmei Lou, Jun Chen, Yangpeng Tang • 2026
Compare Journals
Compare Cell against similar publications in its field:
Metadata
Last updated: Mar 20, 2026
Updated by: system